Allarity Therapeutics, Inc. (ALLR)
NASDAQ: ALLR · Real-Time Price · USD
1.400
0.00 (0.00%)
Aug 7, 2026, 9:41 AM EDT - Market open
Allarity Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 19.81 | 14.69 | 19.53 | 0.17 | 2.03 | 19.56 |
Short-Term Investments | - | - | - | - | - | 0.35 |
Cash & Short-Term Investments | 19.81 | 14.69 | 19.53 | 0.17 | 2.03 | 19.91 |
Cash Growth | -21.38% | -24.81% | 11666.87% | -91.82% | -89.81% | 1641.47% |
Other Receivables | 1.08 | 0.87 | 2.19 | 0.82 | 0.79 | 0.84 |
Total Trade Receivables | 1.08 | 0.87 | 2.19 | 0.82 | 0.79 | 0.84 |
Other Current Assets | 13.61 | 2.38 | 0.62 | 0.99 | 2.15 | 0.66 |
Total Current Assets | 34.5 | 17.93 | 22.34 | 1.97 | 4.97 | 21.4 |
Net Property, Plant & Equipment | 0.42 | 0.33 | 0.31 | 0.02 | 0.03 | 0.09 |
Other Intangible Assets | - | - | - | 9.87 | 9.55 | 28.14 |
Total Assets | 34.92 | 18.26 | 22.65 | 11.86 | 14.54 | 49.63 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 4.24 | 4.28 | 4.18 | 8.42 | 6.25 | 0.7 |
Accrued Expenses | 2.27 | 2.75 | 5.31 | 1.37 | 1.95 | 8.65 |
Short-Term Debt | 20.08 | - | - | - | 2.64 | - |
Current Portion of Long-Term Debt | 1.42 | 1.4 | 1.35 | 1.3 | - | - |
Current Portion of Leases | - | - | - | - | 0.01 | 0.1 |
Other Current Liabilities | - | - | 0 | 3.08 | 0.37 | 11.27 |
Total Current Liabilities | 28 | 8.43 | 10.84 | 14.17 | 11.22 | 20.72 |
Long-Term Debt | - | - | - | - | 1.08 | 0.98 |
Long-Term Leases | - | - | - | - | - | 0.01 |
Other Long-Term Liabilities | - | - | - | 0.45 | 0.35 | 9.14 |
Total Long-Term Liabilities | - | - | - | 0.45 | 1.43 | 10.13 |
Total Liabilities | 28 | 8.43 | 10.84 | 14.61 | 12.65 | 30.85 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | - | 0 |
Treasury Stock | -3.45 | -3.19 | - | - | - | - |
Additional Paid-in Capital | 144.4 | 144.23 | 131.13 | 90.37 | 83.16 | 85.24 |
Accumulated Other Comprehensive Income | -1.08 | -1.02 | -0.35 | -0.41 | -0.72 | -0.6 |
Retained Earnings | -132.95 | -130.2 | -118.97 | -94.45 | -82.55 | -66.49 |
Total Common Shareholders' Equity | 6.92 | 9.83 | 11.81 | -4.49 | -0.11 | 18.15 |
Minority Interest | - | - | - | 1.74 | 4.01 | 1.26 |
Shareholders' Equity | 6.92 | 9.83 | 11.81 | -2.75 | 3.89 | 19.42 |
Total Liabilities & Equity | 34.92 | 18.26 | 22.65 | 11.86 | 14.54 | 49.63 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 21.5 | 1.4 | 1.35 | 1.3 | 3.74 | 1.09 |
Net Cash (Debt) | -1.68 | 13.29 | 18.18 | -1.13 | -1.71 | 18.82 |
Net Cash Growth | - | -26.93% | - | - | - | - |
Net Cash Per Share | -0.11 | 0.92 | 11.31 | - | - | - |
Book Value | 6.92 | 9.83 | 11.81 | -4.49 | -0.11 | 18.15 |
Book Value Per Share | 0.44 | 0.68 | 7.35 | - | - | - |
Tangible Book Value | 6.92 | 9.83 | 11.81 | -14.36 | -9.66 | -9.98 |
Tangible Book Value Per Share | 0.44 | 0.68 | 7.35 | - | - | - |